FDA official logo
GSRS logo
PFDA official logo

DINUTUXIMAB

  • UNII: 7SQY4ZUD30
  • Preferred Substance Name: DINUTUXIMAB

  • 1363687-32-4
  • APN311
  • APN-311
  • CH14.18
  • CH-14.18
  • CH14.18-UTC
  • CH-14.18-UTC
  • CHIMERIC ANTI-DISIALOGANGLIOSIDE (GD2) MONOCLONAL ANTIBODY (CH14.18/CHO)
  • DINUTUXIMAB [INN]
  • DINUTUXIMAB [MI]
  • DINUTUXIMAB [PURPLE BOOK, CDER]
  • DINUTUXIMAB [USAN]
  • DINUTUXIMAB [WHO-DD]
  • DINUTUXIMAB BETA
  • DINUTUXIMAB BETA [INN]
  • DINUTUXIMAB BETA [WHO-DD]
  • IMMUNOGLOBULIN G1, ANTI-(GANGLIOSIDE GD2) (HUMAN-MUS MUSCULUS MONOCLONAL CH14.18 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CH14.18 LIGHT CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(GANGLIOSIDE GD2) (HUMAN-MUS MUSCULUS MONOCLONAL CH14.18/CHO HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CH14.18/CHO LIGHT CHAIN, DIMER
  • QARZIBA
  • UNITUXIN

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.